Please find the attached proceeding of the AGM
Awaiting price reaction for this filing.
Cresanto Global Limited (formerly Raymed Labs Limited) held its 33rd AGM on 29th September 2025 via video conferencing, running for just 12 minutes (4:00 PM to 4:12 PM). A total of 26 members attended, with independent director Mr. Nishant Bajaj chairing the meeting and Managing Director Prashant Nathmal Bajaj present. Six resolutions were approved by shareholders: adoption of the audited standalone and consolidated financial statements for FY ended 31st March 2025, re-appointment of Mr. Nishant Nathmal Bajaj as director (retiring by rotation), appointment of the secretarial auditor, approval of related party transactions, change of the company's name with amendments to the Memorandum and Articles of Association, and a reduction of share capital. Remote e-voting was open from 25th to 28th September via NSDL, and voting results will be shared with BSE within 2 working days.
The two special resolutions — a name change and a reduction of share capital — are significant corporate actions that could alter the stock's market identity and affect per-share metrics. Approval of related party transactions is also worth tracking as it signals ongoing connected-party dealings. Routine items (financials, director re-appointment, secretarial auditor) are largely procedural.